AJANTPHARM vs BROOKS: Stock Comparison
Ajanta Pharma Limited is the larger company by market capitalisation. Ajanta Pharma Limited shows a higher ROE, a higher dividend yield and faster revenue growth, while Brooks Laboratories Limited shows a lower P/E and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
AJANTPHARM leads 7; BROOKS leads 5 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | AJANTPHARM | BROOKS |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | AJANTPHARM | BROOKS |
|---|---|---|
| Live Price | ₹3,639.8 | ₹69.58 |
| Day Change | -0.51% | -3.45% |
| Volume | 51,825 | 91,999 |
| 52-Week High | ₹3,796 | ₹163.9 |
| 52-Week Low | ₹2,329.9 | ₹36.3 |
| Distance from 52W High | -4.11% | -57.55% |
Valuation
| Metric | AJANTPHARM | BROOKS |
|---|---|---|
| Market Cap | ₹45,48,258.56 L Cr | ₹182 Cr |
| P/E Ratio | 40.21x | 8.22x |
| P/B Ratio | 10.08x | 1.65x |
| EPS | ₹90.63 | ₹7.32 |
| Book Value | ₹362.35 | ₹33.3 |
| Dividend Yield | 1.76% | 0% |
Growth
| Metric | AJANTPHARM | BROOKS |
|---|---|---|
| Revenue Growth (TTM YoY) | 21.5% | -6.37% |
| EPS Growth (TTM YoY) | 18.6% | 0% |
| Qtr Sales Growth | 21.5% | 42.3% |
| Qtr Profit Growth | 18.4% | 498% |
Profitability & Leverage
| Metric | AJANTPHARM | BROOKS |
|---|---|---|
| ROE | 27.1% | 20.04% |
| ROCE | 34.5% | -9.93% |
| Net Margin | 19.38% | 28.67% |
| Operating Margin | 27.5% | 7.74% |
| Debt to Equity | 0.06x | 0.06x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | AJANTPHARM | BROOKS |
|---|---|---|
| Promoter Holding | 63.48%▼ 2.77 pp | 52.62% |
| FII Holding | 7.68%▼ 0.58 pp | 0%▼ 0.17 pp |
| DII Holding | 21.8%▲ 3.43 pp | 10.38% |
| Public Holding | 7.03%▼ 0.09 pp | 37%▲ 0.16 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Ajanta Pharma Limited and Brooks Laboratories Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.